InvestorsObserver
×
News Home

Can Citius Pharmaceuticals Inc (CTXR) Stock Rise to the Top of Healthcare Sector Friday?

Friday, January 27, 2023 01:11 PM | InvestorsObserver Analysts

Mentioned in this article

Can Citius Pharmaceuticals Inc (CTXR) Stock Rise to the Top of Healthcare Sector Friday?

Citius Pharmaceuticals Inc (CTXR) is near the top in its sector according to InvestorsObserver. CTXR gets an overall rating of 75. That means it scores higher than 75% of stocks. Citius Pharmaceuticals Inc gets a 80 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.

Overall Score - 75
CTXR has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on CTXR!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Citius Pharmaceuticals Inc Stock Today?

Citius Pharmaceuticals Inc (CTXR) stock is unchanged -0.36% while the S&P 500 has gained 0.43% as of 1:05 PM on Friday, Jan 27. CTXR is unmoved $0.00 from the previous closing price of $1.31 on volume of 470,340 shares. Over the past year the S&P 500 has fallen -5.75% while CTXR is lower by -5.07%. CTXR lost -$0.23 per share the over the last 12 months. Click Here to get the full Stock Report for Citius Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App